Biocon Q4 cons net seen up 5.5% at Rs 64 cr

24120 Investors following Biocon. Share this News with them.

0

Like this story, share it with millions of investors on M3

Biocon Q4 cons net seen up 5.5% at Rs 64 cr

Biocon is to announce its Q4FY08 numbers. According to CNBC-TV18 estimates, the company is likely to post 5.5% growth in its consolidated net profit of Rs 64 crore as against Rs 60.70 crore in same quarter of last year.

Post your opinion here

 

0

Tweet

Share on Tumblr

ALSO READ News and Notices about Biocon See interviews with Biocon Management See what other Experts & Brokerages are saying about Biocon See previous Results of Biocon Biocon BSE | NSE 25/05/12 Are Mutual Funds betting on Biocon?

Biocon is to announce its Q4FY08 numbers. According to CNBC-TV18 estimates, the company is likely to post 5.5% growth in its consolidated net profit of Rs 64 crore as against Rs 60.70 crore in same quarter of last year.

Net sales is seen going up 2% at Rs 284.30 crore versus Rs 278.24 crore. Operating profit is expected to be at Rs 80.6 crore versus Rs 85.7 crore. OPM is seen at 28.35% versus 30.80%.

Factors to watch

• Sales growth to be only 5% due to divestment of enzyme business
• EBIDTA margins to come down on account of higher R&D expenditure
• Expect lower growth in contract research services due to rupee appreciation